KoreaTimes - Bio

The Korea Times

The Korea Times

The Korea Times

Business

Bio

Tue, September 26, 2023 | 16:15

SK bioscience to establish vaccine production, development infrastructure in Thailand

SK bioscience to establish vaccine production, development infrastructure in Thailand

SK bioscience signed an agreement with a bio company run by the Thai government to build vaccine production facilities and infrastructure as part of the Korean vaccine developer's globalization strategy, according to the company, Wednesday.

Baek Byung-yeul | 2023-07-05 16:30

Samsung Biologics signs $897 mil. drug production deal with Pfizer

Samsung Biologics signs $897 mil. drug production deal with Pfizer

Samsung Biologics signed two biosimilar product-manufacturing contracts with global pharmaceutical company Pfizer, totaling $897 million, demonstrating the growing reputation of the Korean contract-based drug manufacturer, the company said Tuesday.

Baek Byung-yeul | 2023-07-04 16:35

SK bioscience completes Phase 2 trial for pneumococcal vaccine

SK bioscience completes Phase 2 trial for pneumococcal vaccine

SK bioscience successfully completed the Phase 2 clinical trial of a 21-valent pneumococcal vaccine co-developed with French biopharmaceutical company Sanofi and is on track to enter the Phase 3 trial, according to the local vaccine developer and producer, Friday.

Baek Byung-yeul | 2023-07-02 15:55

Kakao Healthcare to launch glucose managing service with Dexcom

Kakao Healthcare to launch glucose managing service with Dexcom

Kakao Healthcare will launch a glucose managing service in the global market including the United States, Korea, Japan and the Middle East in collaboration with the U.S.-based glucose monitoring device maker Dexcom, the healthcare subsidiary of Kakao said Thursday. Kakao Healthcare and Dexcom signed a memorandum of understanding in Boston last April to pursue a global joint b...

Baek Byung-yeul | 2023-06-22 16:42

Korea to foster local bio industry to produce $76.9 bil. by 2030

Korea to foster local bio industry to produce $76.9 bil. by 2030

The Korean government said Wednesday that it will give full support to the local biotechnology industry to raise the sector's production capacity to 100 trillion won ($76.9 billion) by 2030 as part of its plans to become the world-leading biotech economy.

2023-06-07 11:27

Korean bio firms to seek new opportunities at int'l convention in Boston

Korean bio firms to seek new opportunities at int'l convention in Boston

Samsung Biologics, Celltrion and other Korean biotechnology companies are heading to Boston to take part in the BIO International Convention, also known as BIO USA, to promote their technologies and products and to seek new business opportunities at one of the largest exhibitions in the global bio industry, according to the companies, Sunday.

Baek Byung-yeul | 2023-06-04 16:41

Centrum launches new probiotic products in Korea

Centrum launches new probiotic products in Korea

Centrum, a multivitamin brand of global healthcare company Haleon's, will launch three new probiotics products made by its Korean R&D center and produced by its Korean contract manufacturing organization (CMO) partner in order to improve its presence in the country's growing probiotics market, according to the company, Wednesday.

Baek Byung-yeul | 2023-05-31 15:48

Korea to foster biotechnology as new growth engine: finance minister

Korea to foster biotechnology as new growth engine: finance minister

Korea will lift regulations to help biotechnology startups utilize the database of hospitals, and foster the industry as a new growth engine, the finance minister said Wednesday.

2023-05-24 17:18

SK bioscience calls for global cooperation on sharing vaccine manufacturing capacity

SK bioscience calls for global cooperation on sharing vaccine manufacturing capacity

SK bioscience, a pharmaceutical affiliate under Korea's SK Group, said Tuesday it has called for stronger global cooperation to share vaccine manufacturing capabilities with underdeveloped countries for wider access to vaccines in a future pandemic.

2023-05-23 17:15

HLB seeks approval for liver cancer drug with US FDA

HLB seeks approval for liver cancer drug with US FDA

HLB, an international biopharmaceutical company, submitted a new drug application (NDA) for its Rivoceranib liver cancer drug to the U.S. Food and Drug Administration (FDA) on Tuesday. If successful, it would become the first Korean biotechnology company to win a new drug approval in the U.S., the company said Thursday.

Baek Byung-yeul | 2023-05-18 16:27

1 2 3 4 5 6 7 8 9 10

Top 10 Stories

1	4 in 10 Koreans experience overdue wages: survey

2	Tanghulu captures hearts of Korean millennials and Gen Z

3	PHOTOSHarvest season arrives

4	K-pop fans rally in Seoul against luxury brands' failure on climate action

5	Korean gov't faces international criticism for R&D budget cuts

6	LG Uplus, Hanwha develop ceiling-mounted EV charging system

7	Korea has world's highest senior poverty rate: data

8	EXCLUSIVELawmakers to submit resolution urging China to free N. Korean escapees

9	SK earthon begins crude oil production in South China Sea

10	Main opposition chief in showdown with prosecutors over arrest

DARKROOM